1. Binimetinib, pemetrexed and cisplatin, followed by maintenance of binimetinib and pemetrexed in patients with advanced non-small cell lung cancer (NSCLC) and KRAS mutations. The phase 1B SAKK 19/16 trial. (June 2021) Authors: Froesch, Patrizia; Mark, Michael; Rothschild, Sacha I.; Li, Qiyu; Godar, Gilles; Rusterholz, Corinne; Oppliger Leibundgut, Elisabeth; Schmid, Sabine; Colombo, Ilaria; Metaxas, Yannis; König, David; Sessa, Cristiana; Gautschi, Oliver; Früh, Martin Journal: Lung cancer Issue: Volume 156(2021) Page Start: 91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer. Issue 3 (15th March 2022) Authors: Klümper, Niklas; Saal, Jonas; Berner, Fiamma; Lichtensteiger, Christa; Wyss, Nina; Heine, Annkristin; Bauernfeind, Franz Georg; Ellinger, Jörg; Brossart, Peter; Diem, Stefan; Schmid, Sabine; Joerger, Markus; Frueh, Martin; Ritter, Manuel; Hölzel, Michael; Flatz, Lukas; Bald, Tobias Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 3(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Does progress achieved in the treatment of patients with metastatic non‐small‐cell lung cancer reach the elderly population? A cohort study from a cancer centre from Eastern Switzerland. (21st January 2020) Authors: Schmid, Sabine; Suipyte, Jorune; Herrmann, Christian; Mousavi, Mohsen; Hitz, Felicitas; Früh, Martin Journal: European journal of cancer care Issue: Volume 29:Number 2(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Half a century of Krypton-85 activity concentration measured in air over Central Europe: Trends and relevance for dating young groundwater. (September 2019) Authors: Bollhöfer, Andreas; Schlosser, Clemens; Schmid, Sabine; Konrad, Martina; Purtschert, Roland; Krais, Roman Journal: Journal of environmental radioactivity Issue: Volume 205/206(2019) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Interplay of demographic variables, birth experience, and initial reactions in the prediction of symptoms of posttraumatic stress one year after giving birth. Issue 1 (1st December 2016) Authors: König, Julia; Schmid, Sabine; Löser, Eva; Neumann, Olaf; Buchholz, Stefan; Kästner, Ralph Journal: European journal of psychotraumatology Issue: Volume 7:Issue 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. IRECIST and atypical patterns of response to immuno-oncology drugs. Issue 6 (17th June 2022) Authors: Ramon-Patino, Jorge Luis; Schmid, Sabine; Lau, Sally; Seymour, Lesley; Gaudreau, Pierre-Olivier; Li, Janice Juan Ning; Bradbury, Penelope Ann; Calvo, Emiliano Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Management of Children with Travel-related Illness Evaluated in a Pediatric Emergency Room. Issue 12 (December 2015) Authors: Leuthard, Deborah; Berger, Christoph; Staubli, Georg; Nadal, David; Schmid, Sabine; Hamer, David; Weber, Rainer; Schlagenhauf, Patricia Journal: Pediatric infectious disease journal Issue: Volume 34:Issue 12(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Mechanisms of osimertinib resistance and emerging treatment options. (September 2020) Authors: Schmid, Sabine; Li, Janice J.N.; Leighl, Natasha B. Journal: Lung cancer Issue: Volume 147(2020) Page Start: 123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. (September 2017) Authors: Diem, Stefan; Schmid, Sabine; Krapf, Mirjam; Flatz, Lukas; Born, Diana; Jochum, Wolfram; Templeton, Arnoud J.; Früh, Martin Journal: Lung cancer Issue: Volume 111(2017) Page Start: 176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Real‐world outcomes using PD‐1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland. (12th December 2022) Authors: Schumann, Katharina; Mauch, Cornelia; Klespe, Kai‐Christian; Loquai, Carmen; Nikfarjam, Ulrike; Schlaak, Max; Akçetin, Larissa; Kölblinger, Peter; Hoellwerth, Magdalena; Meissner, Markus; Mengi, Guelcin; Braun, Andreas Dominik; Mengoni, Miriam; Dummer, Reinhard; Mangana, Joanna; Sindrilaru, Mihae... Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 37:Number 5(2023) Page Start: 894 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗